フィナステリド経口錠剤のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Finasteride Oral Tablet Market Insights, Forecast to 2028

• レポートコード：QY2207C3833 • 出版社/出版日：QYResearch / 2022年7月11日 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界のフィナステリド経口錠剤の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にフィナステリド経口錠剤の世界市場のxxx％を占める「1mg錠」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「良性前立腺肥大症」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のフィナステリド経口錠剤の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのフィナステリド経口錠剤市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのフィナステリド経口錠剤市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 フィナステリド経口錠剤のグローバル主要メーカーには、Merck、Accord Healthcare UK、Relonchem、Sandoz、Teva Generics、Cipla、Dr. Reddy、Aurobindo Pharma、Henan Topfond、Zhejiang CONBA Pharmaceutical、Shandong Renhetang Pharmaceutical、Guangdong Eashu Pharmacetical、Shanghai Shyndec Pharmaceutical Co.,Ltd.などがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 フィナステリド経口錠剤市場は、種類と用途によって区分されます。世界のフィナステリド経口錠剤市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 1mg錠、5mg錠 【用途別セグメント】 良性前立腺肥大症、男性型脱毛症、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - フィナステリド経口錠剤製品概要 - 種類別市場（1mg錠、5mg錠） - 用途別市場（良性前立腺肥大症、男性型脱毛症、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のフィナステリド経口錠剤販売量予測2017-2028 - 世界のフィナステリド経口錠剤売上予測2017-2028 - フィナステリド経口錠剤の地域別販売量 - フィナステリド経口錠剤の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別フィナステリド経口錠剤販売量 - 主要メーカー別フィナステリド経口錠剤売上 - 主要メーカー別フィナステリド経口錠剤価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（1mg錠、5mg錠） - フィナステリド経口錠剤の種類別販売量 - フィナステリド経口錠剤の種類別売上 - フィナステリド経口錠剤の種類別価格 ・用途別市場規模（良性前立腺肥大症、男性型脱毛症、その他） - フィナステリド経口錠剤の用途別販売量 - フィナステリド経口錠剤の用途別売上 - フィナステリド経口錠剤の用途別価格 ・北米市場 - 北米のフィナステリド経口錠剤市場規模（種類別、用途別） - 主要国別のフィナステリド経口錠剤市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのフィナステリド経口錠剤市場規模（種類別、用途別） - 主要国別のフィナステリド経口錠剤市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のフィナステリド経口錠剤市場規模（種類別、用途別） - 主要国別のフィナステリド経口錠剤市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のフィナステリド経口錠剤市場規模（種類別、用途別） - 主要国別のフィナステリド経口錠剤市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのフィナステリド経口錠剤市場規模（種類別、用途別） - 主要国別のフィナステリド経口錠剤市場規模（トルコ、サウジアラビア） ・企業情報 Merck、Accord Healthcare UK、Relonchem、Sandoz、Teva Generics、Cipla、Dr. Reddy、Aurobindo Pharma、Henan Topfond、Zhejiang CONBA Pharmaceutical、Shandong Renhetang Pharmaceutical、Guangdong Eashu Pharmacetical、Shanghai Shyndec Pharmaceutical Co.,Ltd. ・産業チェーン及び販売チャネル分析 - フィナステリド経口錠剤の産業チェーン分析 - フィナステリド経口錠剤の原材料 - フィナステリド経口錠剤の生産プロセス - フィナステリド経口錠剤の販売及びマーケティング - フィナステリド経口錠剤の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - フィナステリド経口錠剤の産業動向 - フィナステリド経口錠剤のマーケットドライバー - フィナステリド経口錠剤の課題 - フィナステリド経口錠剤の阻害要因 ・主な調査結果

Finasteride Oral Tablet is a medication used for the treatment of benign prostatic hyperplasia (BPH) and male pattern baldness (MPB).
Market Analysis and Insights: Global Finasteride Oral Tablet Market
Due to the COVID-19 pandemic, the global Finasteride Oral Tablet market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, 1mg Tablet accounting for % of the Finasteride Oral Tablet global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Benign Prostatic Hyperplasia segment is altered to an % CAGR throughout this forecast period.
China Finasteride Oral Tablet market size is valued at US$ million in 2021, while the US and Europe Finasteride Oral Tablet are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Finasteride Oral Tablet landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Finasteride Oral Tablet include Merck, Accord Healthcare UK, Relonchem, Sandoz, Teva Generics, Cipla, Dr. Reddy, Aurobindo Pharma and Henan Topfond, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Finasteride Oral Tablet Scope and Segment
Finasteride Oral Tablet market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Finasteride Oral Tablet market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
1mg Tablet
5mg Tablet
Segment by Application
Benign Prostatic Hyperplasia
Male Pattern Baldness
Others
By Company
Merck
Accord Healthcare UK
Relonchem
Sandoz
Teva Generics
Cipla
Dr. Reddy
Aurobindo Pharma
Henan Topfond
Zhejiang CONBA Pharmaceutical
Shandong Renhetang Pharmaceutical
Guangdong Eashu Pharmacetical
Shanghai Shyndec Pharmaceutical Co.,Ltd.
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Finasteride Oral Tablet Product Introduction
1.2 Market by Type
1.2.1 Global Finasteride Oral Tablet Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 1mg Tablet
1.2.3 5mg Tablet
1.3 Market by Application
1.3.1 Global Finasteride Oral Tablet Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Benign Prostatic Hyperplasia
1.3.3 Male Pattern Baldness
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Finasteride Oral Tablet Sales Estimates and Forecasts 2017-2028
2.2 Global Finasteride Oral Tablet Revenue Estimates and Forecasts 2017-2028
2.3 Global Finasteride Oral Tablet Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Finasteride Oral Tablet Sales by Region
2.4.1 Global Finasteride Oral Tablet Sales by Region (2017-2022)
2.4.2 Global Sales Finasteride Oral Tablet by Region (2023-2028)
2.5 Global Finasteride Oral Tablet Revenue by Region
2.5.1 Global Finasteride Oral Tablet Revenue by Region (2017-2022)
2.5.2 Global Finasteride Oral Tablet Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Finasteride Oral Tablet Sales by Manufacturers
3.1.1 Global Top Finasteride Oral Tablet Manufacturers by Sales (2017-2022)
3.1.2 Global Finasteride Oral Tablet Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Finasteride Oral Tablet in 2021
3.2 Global Finasteride Oral Tablet Revenue by Manufacturers
3.2.1 Global Finasteride Oral Tablet Revenue by Manufacturers (2017-2022)
3.2.2 Global Finasteride Oral Tablet Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Finasteride Oral Tablet Revenue in 2021
3.3 Global Finasteride Oral Tablet Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Finasteride Oral Tablet Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Finasteride Oral Tablet Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Finasteride Oral Tablet Sales by Type
4.1.1 Global Finasteride Oral Tablet Historical Sales by Type (2017-2022)
4.1.2 Global Finasteride Oral Tablet Forecasted Sales by Type (2023-2028)
4.1.3 Global Finasteride Oral Tablet Sales Market Share by Type (2017-2028)
4.2 Global Finasteride Oral Tablet Revenue by Type
4.2.1 Global Finasteride Oral Tablet Historical Revenue by Type (2017-2022)
4.2.2 Global Finasteride Oral Tablet Forecasted Revenue by Type (2023-2028)
4.2.3 Global Finasteride Oral Tablet Revenue Market Share by Type (2017-2028)
4.3 Global Finasteride Oral Tablet Price by Type
4.3.1 Global Finasteride Oral Tablet Price by Type (2017-2022)
4.3.2 Global Finasteride Oral Tablet Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Finasteride Oral Tablet Sales by Application
5.1.1 Global Finasteride Oral Tablet Historical Sales by Application (2017-2022)
5.1.2 Global Finasteride Oral Tablet Forecasted Sales by Application (2023-2028)
5.1.3 Global Finasteride Oral Tablet Sales Market Share by Application (2017-2028)
5.2 Global Finasteride Oral Tablet Revenue by Application
5.2.1 Global Finasteride Oral Tablet Historical Revenue by Application (2017-2022)
5.2.2 Global Finasteride Oral Tablet Forecasted Revenue by Application (2023-2028)
5.2.3 Global Finasteride Oral Tablet Revenue Market Share by Application (2017-2028)
5.3 Global Finasteride Oral Tablet Price by Application
5.3.1 Global Finasteride Oral Tablet Price by Application (2017-2022)
5.3.2 Global Finasteride Oral Tablet Price Forecast by Application (2023-2028)
6 North America
6.1 North America Finasteride Oral Tablet Market Size by Type
6.1.1 North America Finasteride Oral Tablet Sales by Type (2017-2028)
6.1.2 North America Finasteride Oral Tablet Revenue by Type (2017-2028)
6.2 North America Finasteride Oral Tablet Market Size by Application
6.2.1 North America Finasteride Oral Tablet Sales by Application (2017-2028)
6.2.2 North America Finasteride Oral Tablet Revenue by Application (2017-2028)
6.3 North America Finasteride Oral Tablet Market Size by Country
6.3.1 North America Finasteride Oral Tablet Sales by Country (2017-2028)
6.3.2 North America Finasteride Oral Tablet Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Finasteride Oral Tablet Market Size by Type
7.1.1 Europe Finasteride Oral Tablet Sales by Type (2017-2028)
7.1.2 Europe Finasteride Oral Tablet Revenue by Type (2017-2028)
7.2 Europe Finasteride Oral Tablet Market Size by Application
7.2.1 Europe Finasteride Oral Tablet Sales by Application (2017-2028)
7.2.2 Europe Finasteride Oral Tablet Revenue by Application (2017-2028)
7.3 Europe Finasteride Oral Tablet Market Size by Country
7.3.1 Europe Finasteride Oral Tablet Sales by Country (2017-2028)
7.3.2 Europe Finasteride Oral Tablet Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Finasteride Oral Tablet Market Size by Type
8.1.1 Asia Pacific Finasteride Oral Tablet Sales by Type (2017-2028)
8.1.2 Asia Pacific Finasteride Oral Tablet Revenue by Type (2017-2028)
8.2 Asia Pacific Finasteride Oral Tablet Market Size by Application
8.2.1 Asia Pacific Finasteride Oral Tablet Sales by Application (2017-2028)
8.2.2 Asia Pacific Finasteride Oral Tablet Revenue by Application (2017-2028)
8.3 Asia Pacific Finasteride Oral Tablet Market Size by Region
8.3.1 Asia Pacific Finasteride Oral Tablet Sales by Region (2017-2028)
8.3.2 Asia Pacific Finasteride Oral Tablet Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Finasteride Oral Tablet Market Size by Type
9.1.1 Latin America Finasteride Oral Tablet Sales by Type (2017-2028)
9.1.2 Latin America Finasteride Oral Tablet Revenue by Type (2017-2028)
9.2 Latin America Finasteride Oral Tablet Market Size by Application
9.2.1 Latin America Finasteride Oral Tablet Sales by Application (2017-2028)
9.2.2 Latin America Finasteride Oral Tablet Revenue by Application (2017-2028)
9.3 Latin America Finasteride Oral Tablet Market Size by Country
9.3.1 Latin America Finasteride Oral Tablet Sales by Country (2017-2028)
9.3.2 Latin America Finasteride Oral Tablet Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Finasteride Oral Tablet Market Size by Type
10.1.1 Middle East and Africa Finasteride Oral Tablet Sales by Type (2017-2028)
10.1.2 Middle East and Africa Finasteride Oral Tablet Revenue by Type (2017-2028)
10.2 Middle East and Africa Finasteride Oral Tablet Market Size by Application
10.2.1 Middle East and Africa Finasteride Oral Tablet Sales by Application (2017-2028)
10.2.2 Middle East and Africa Finasteride Oral Tablet Revenue by Application (2017-2028)
10.3 Middle East and Africa Finasteride Oral Tablet Market Size by Country
10.3.1 Middle East and Africa Finasteride Oral Tablet Sales by Country (2017-2028)
10.3.2 Middle East and Africa Finasteride Oral Tablet Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Overview
11.1.3 Merck Finasteride Oral Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Merck Finasteride Oral Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 Accord Healthcare UK
11.2.1 Accord Healthcare UK Corporation Information
11.2.2 Accord Healthcare UK Overview
11.2.3 Accord Healthcare UK Finasteride Oral Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Accord Healthcare UK Finasteride Oral Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Accord Healthcare UK Recent Developments
11.3 Relonchem
11.3.1 Relonchem Corporation Information
11.3.2 Relonchem Overview
11.3.3 Relonchem Finasteride Oral Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Relonchem Finasteride Oral Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Relonchem Recent Developments
11.4 Sandoz
11.4.1 Sandoz Corporation Information
11.4.2 Sandoz Overview
11.4.3 Sandoz Finasteride Oral Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Sandoz Finasteride Oral Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sandoz Recent Developments
11.5 Teva Generics
11.5.1 Teva Generics Corporation Information
11.5.2 Teva Generics Overview
11.5.3 Teva Generics Finasteride Oral Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Teva Generics Finasteride Oral Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Teva Generics Recent Developments
11.6 Cipla
11.6.1 Cipla Corporation Information
11.6.2 Cipla Overview
11.6.3 Cipla Finasteride Oral Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Cipla Finasteride Oral Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Cipla Recent Developments
11.7 Dr. Reddy
11.7.1 Dr. Reddy Corporation Information
11.7.2 Dr. Reddy Overview
11.7.3 Dr. Reddy Finasteride Oral Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Dr. Reddy Finasteride Oral Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Dr. Reddy Recent Developments
11.8 Aurobindo Pharma
11.8.1 Aurobindo Pharma Corporation Information
11.8.2 Aurobindo Pharma Overview
11.8.3 Aurobindo Pharma Finasteride Oral Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Aurobindo Pharma Finasteride Oral Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Aurobindo Pharma Recent Developments
11.9 Henan Topfond
11.9.1 Henan Topfond Corporation Information
11.9.2 Henan Topfond Overview
11.9.3 Henan Topfond Finasteride Oral Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Henan Topfond Finasteride Oral Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Henan Topfond Recent Developments
11.10 Zhejiang CONBA Pharmaceutical
11.10.1 Zhejiang CONBA Pharmaceutical Corporation Information
11.10.2 Zhejiang CONBA Pharmaceutical Overview
11.10.3 Zhejiang CONBA Pharmaceutical Finasteride Oral Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Zhejiang CONBA Pharmaceutical Finasteride Oral Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Zhejiang CONBA Pharmaceutical Recent Developments
11.11 Shandong Renhetang Pharmaceutical
11.11.1 Shandong Renhetang Pharmaceutical Corporation Information
11.11.2 Shandong Renhetang Pharmaceutical Overview
11.11.3 Shandong Renhetang Pharmaceutical Finasteride Oral Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Shandong Renhetang Pharmaceutical Finasteride Oral Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Shandong Renhetang Pharmaceutical Recent Developments
11.12 Guangdong Eashu Pharmacetical
11.12.1 Guangdong Eashu Pharmacetical Corporation Information
11.12.2 Guangdong Eashu Pharmacetical Overview
11.12.3 Guangdong Eashu Pharmacetical Finasteride Oral Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Guangdong Eashu Pharmacetical Finasteride Oral Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Guangdong Eashu Pharmacetical Recent Developments
11.13 Shanghai Shyndec Pharmaceutical Co.,Ltd.
11.13.1 Shanghai Shyndec Pharmaceutical Co.,Ltd. Corporation Information
11.13.2 Shanghai Shyndec Pharmaceutical Co.,Ltd. Overview
11.13.3 Shanghai Shyndec Pharmaceutical Co.,Ltd. Finasteride Oral Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Shanghai Shyndec Pharmaceutical Co.,Ltd. Finasteride Oral Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Shanghai Shyndec Pharmaceutical Co.,Ltd. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Finasteride Oral Tablet Industry Chain Analysis
12.2 Finasteride Oral Tablet Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Finasteride Oral Tablet Production Mode & Process
12.4 Finasteride Oral Tablet Sales and Marketing
12.4.1 Finasteride Oral Tablet Sales Channels
12.4.2 Finasteride Oral Tablet Distributors
12.5 Finasteride Oral Tablet Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Finasteride Oral Tablet Industry Trends
13.2 Finasteride Oral Tablet Market Drivers
13.3 Finasteride Oral Tablet Market Challenges
13.4 Finasteride Oral Tablet Market Restraints
14 Key Findings in The Global Finasteride Oral Tablet Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Finasteride Oral Tablet Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 1mg Tablet
Table 3. Major Manufacturers of 5mg Tablet
Table 4. Global Finasteride Oral Tablet Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Finasteride Oral Tablet Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Finasteride Oral Tablet Sales by Region (2017-2022) & (K Units)
Table 7. Global Finasteride Oral Tablet Sales Market Share by Region (2017-2022)
Table 8. Global Finasteride Oral Tablet Sales by Region (2023-2028) & (K Units)
Table 9. Global Finasteride Oral Tablet Sales Market Share by Region (2023-2028)
Table 10. Global Finasteride Oral Tablet Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Finasteride Oral Tablet Revenue Market Share by Region (2017-2022)
Table 12. Global Finasteride Oral Tablet Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Finasteride Oral Tablet Revenue Market Share by Region (2023-2028)
Table 14. Global Finasteride Oral Tablet Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Finasteride Oral Tablet Sales Share by Manufacturers (2017-2022)
Table 16. Global Finasteride Oral Tablet Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Finasteride Oral Tablet Revenue Share by Manufacturers (2017-2022)
Table 18. Finasteride Oral Tablet Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Finasteride Oral Tablet Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Finasteride Oral Tablet by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Finasteride Oral Tablet as of 2021)
Table 21. Finasteride Oral Tablet Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Finasteride Oral Tablet Product Offered
Table 23. Date of Manufacturers Enter into Finasteride Oral Tablet Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Finasteride Oral Tablet Sales by Type (2017-2022) & (K Units)
Table 26. Global Finasteride Oral Tablet Sales by Type (2023-2028) & (K Units)
Table 27. Global Finasteride Oral Tablet Sales Share by Type (2017-2022)
Table 28. Global Finasteride Oral Tablet Sales Share by Type (2023-2028)
Table 29. Global Finasteride Oral Tablet Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Finasteride Oral Tablet Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Finasteride Oral Tablet Revenue Share by Type (2017-2022)
Table 32. Global Finasteride Oral Tablet Revenue Share by Type (2023-2028)
Table 33. Finasteride Oral Tablet Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Finasteride Oral Tablet Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Finasteride Oral Tablet Sales by Application (2017-2022) & (K Units)
Table 36. Global Finasteride Oral Tablet Sales by Application (2023-2028) & (K Units)
Table 37. Global Finasteride Oral Tablet Sales Share by Application (2017-2022)
Table 38. Global Finasteride Oral Tablet Sales Share by Application (2023-2028)
Table 39. Global Finasteride Oral Tablet Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Finasteride Oral Tablet Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Finasteride Oral Tablet Revenue Share by Application (2017-2022)
Table 42. Global Finasteride Oral Tablet Revenue Share by Application (2023-2028)
Table 43. Finasteride Oral Tablet Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Finasteride Oral Tablet Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Finasteride Oral Tablet Sales by Type (2017-2022) & (K Units)
Table 46. North America Finasteride Oral Tablet Sales by Type (2023-2028) & (K Units)
Table 47. North America Finasteride Oral Tablet Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Finasteride Oral Tablet Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Finasteride Oral Tablet Sales by Application (2017-2022) & (K Units)
Table 50. North America Finasteride Oral Tablet Sales by Application (2023-2028) & (K Units)
Table 51. North America Finasteride Oral Tablet Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Finasteride Oral Tablet Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Finasteride Oral Tablet Sales by Country (2017-2022) & (K Units)
Table 54. North America Finasteride Oral Tablet Sales by Country (2023-2028) & (K Units)
Table 55. North America Finasteride Oral Tablet Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Finasteride Oral Tablet Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Finasteride Oral Tablet Sales by Type (2017-2022) & (K Units)
Table 58. Europe Finasteride Oral Tablet Sales by Type (2023-2028) & (K Units)
Table 59. Europe Finasteride Oral Tablet Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Finasteride Oral Tablet Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Finasteride Oral Tablet Sales by Application (2017-2022) & (K Units)
Table 62. Europe Finasteride Oral Tablet Sales by Application (2023-2028) & (K Units)
Table 63. Europe Finasteride Oral Tablet Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Finasteride Oral Tablet Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Finasteride Oral Tablet Sales by Country (2017-2022) & (K Units)
Table 66. Europe Finasteride Oral Tablet Sales by Country (2023-2028) & (K Units)
Table 67. Europe Finasteride Oral Tablet Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Finasteride Oral Tablet Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Finasteride Oral Tablet Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Finasteride Oral Tablet Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Finasteride Oral Tablet Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Finasteride Oral Tablet Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Finasteride Oral Tablet Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Finasteride Oral Tablet Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Finasteride Oral Tablet Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Finasteride Oral Tablet Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Finasteride Oral Tablet Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Finasteride Oral Tablet Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Finasteride Oral Tablet Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Finasteride Oral Tablet Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Finasteride Oral Tablet Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Finasteride Oral Tablet Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Finasteride Oral Tablet Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Finasteride Oral Tablet Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Finasteride Oral Tablet Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Finasteride Oral Tablet Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Finasteride Oral Tablet Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Finasteride Oral Tablet Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Finasteride Oral Tablet Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Finasteride Oral Tablet Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Finasteride Oral Tablet Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Finasteride Oral Tablet Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Finasteride Oral Tablet Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Finasteride Oral Tablet Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Finasteride Oral Tablet Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Finasteride Oral Tablet Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Finasteride Oral Tablet Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Finasteride Oral Tablet Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Finasteride Oral Tablet Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Finasteride Oral Tablet Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Finasteride Oral Tablet Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Finasteride Oral Tablet Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Finasteride Oral Tablet Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Finasteride Oral Tablet Revenue by Country (2023-2028) & (US$ Million)
Table 105. Merck Corporation Information
Table 106. Merck Description and Major Businesses
Table 107. Merck Finasteride Oral Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. Merck Finasteride Oral Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Merck Recent Developments
Table 110. Accord Healthcare UK Corporation Information
Table 111. Accord Healthcare UK Description and Major Businesses
Table 112. Accord Healthcare UK Finasteride Oral Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. Accord Healthcare UK Finasteride Oral Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Accord Healthcare UK Recent Developments
Table 115. Relonchem Corporation Information
Table 116. Relonchem Description and Major Businesses
Table 117. Relonchem Finasteride Oral Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. Relonchem Finasteride Oral Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Relonchem Recent Developments
Table 120. Sandoz Corporation Information
Table 121. Sandoz Description and Major Businesses
Table 122. Sandoz Finasteride Oral Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. Sandoz Finasteride Oral Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Sandoz Recent Developments
Table 125. Teva Generics Corporation Information
Table 126. Teva Generics Description and Major Businesses
Table 127. Teva Generics Finasteride Oral Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. Teva Generics Finasteride Oral Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Teva Generics Recent Developments
Table 130. Cipla Corporation Information
Table 131. Cipla Description and Major Businesses
Table 132. Cipla Finasteride Oral Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. Cipla Finasteride Oral Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Cipla Recent Developments
Table 135. Dr. Reddy Corporation Information
Table 136. Dr. Reddy Description and Major Businesses
Table 137. Dr. Reddy Finasteride Oral Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 138. Dr. Reddy Finasteride Oral Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Dr. Reddy Recent Developments
Table 140. Aurobindo Pharma Corporation Information
Table 141. Aurobindo Pharma Description and Major Businesses
Table 142. Aurobindo Pharma Finasteride Oral Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 143. Aurobindo Pharma Finasteride Oral Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Aurobindo Pharma Recent Developments
Table 145. Henan Topfond Corporation Information
Table 146. Henan Topfond Description and Major Businesses
Table 147. Henan Topfond Finasteride Oral Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 148. Henan Topfond Finasteride Oral Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Henan Topfond Recent Developments
Table 150. Zhejiang CONBA Pharmaceutical Corporation Information
Table 151. Zhejiang CONBA Pharmaceutical Description and Major Businesses
Table 152. Zhejiang CONBA Pharmaceutical Finasteride Oral Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 153. Zhejiang CONBA Pharmaceutical Finasteride Oral Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Zhejiang CONBA Pharmaceutical Recent Developments
Table 155. Shandong Renhetang Pharmaceutical Corporation Information
Table 156. Shandong Renhetang Pharmaceutical Description and Major Businesses
Table 157. Shandong Renhetang Pharmaceutical Finasteride Oral Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 158. Shandong Renhetang Pharmaceutical Finasteride Oral Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Shandong Renhetang Pharmaceutical Recent Developments
Table 160. Guangdong Eashu Pharmacetical Corporation Information
Table 161. Guangdong Eashu Pharmacetical Description and Major Businesses
Table 162. Guangdong Eashu Pharmacetical Finasteride Oral Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 163. Guangdong Eashu Pharmacetical Finasteride Oral Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Guangdong Eashu Pharmacetical Recent Developments
Table 165. Shanghai Shyndec Pharmaceutical Co.,Ltd. Corporation Information
Table 166. Shanghai Shyndec Pharmaceutical Co.,Ltd. Description and Major Businesses
Table 167. Shanghai Shyndec Pharmaceutical Co.,Ltd. Finasteride Oral Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 168. Shanghai Shyndec Pharmaceutical Co.,Ltd. Finasteride Oral Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Shanghai Shyndec Pharmaceutical Co.,Ltd. Recent Developments
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Finasteride Oral Tablet Distributors List
Table 173. Finasteride Oral Tablet Customers List
Table 174. Finasteride Oral Tablet Market Trends
Table 175. Finasteride Oral Tablet Market Drivers
Table 176. Finasteride Oral Tablet Market Challenges
Table 177. Finasteride Oral Tablet Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Finasteride Oral Tablet Product Picture
Figure 3. Global Finasteride Oral Tablet Market Share by Type in 2021 & 2028
Figure 3. 1mg Tablet Product Picture
Figure 4. 5mg Tablet Product Picture
Figure 5. Global Finasteride Oral Tablet Market Share by Application in 2021 & 2028
Figure 6. Benign Prostatic Hyperplasia
Figure 7. Male Pattern Baldness
Figure 8. Others
Figure 9. Finasteride Oral Tablet Report Years Considered
Figure 10. Global Finasteride Oral Tablet Sales 2017-2028 (K Units)
Figure 11. Global Finasteride Oral Tablet Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Finasteride Oral Tablet Revenue 2017-2028 (US$ Million)
Figure 13. Global Finasteride Oral Tablet Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Finasteride Oral Tablet Sales Market Share by Region (2017-2022)
Figure 15. Global Finasteride Oral Tablet Sales Market Share by Region (2023-2028)
Figure 16. North America Finasteride Oral Tablet Sales YoY (2017-2028) & (K Units)
Figure 17. North America Finasteride Oral Tablet Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Finasteride Oral Tablet Sales YoY (2017-2028) & (K Units)
Figure 19. Europe Finasteride Oral Tablet Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Finasteride Oral Tablet Sales YoY (2017-2028) & (K Units)
Figure 21. Asia-Pacific Finasteride Oral Tablet Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Finasteride Oral Tablet Sales YoY (2017-2028) & (K Units)
Figure 23. Latin America Finasteride Oral Tablet Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Finasteride Oral Tablet Sales YoY (2017-2028) & (K Units)
Figure 25. Middle East & Africa Finasteride Oral Tablet Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Finasteride Oral Tablet Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Finasteride Oral Tablet in the World: Market Share by Finasteride Oral Tablet Revenue in 2021
Figure 28. Global Finasteride Oral Tablet Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Finasteride Oral Tablet Sales Market Share by Type (2017-2028)
Figure 30. Global Finasteride Oral Tablet Revenue Market Share by Type (2017-2028)
Figure 31. Global Finasteride Oral Tablet Sales Market Share by Application (2017-2028)
Figure 32. Global Finasteride Oral Tablet Revenue Market Share by Application (2017-2028)
Figure 33. North America Finasteride Oral Tablet Sales Market Share by Type (2017-2028)
Figure 34. North America Finasteride Oral Tablet Revenue Market Share by Type (2017-2028)
Figure 35. North America Finasteride Oral Tablet Sales Market Share by Application (2017-2028)
Figure 36. North America Finasteride Oral Tablet Revenue Market Share by Application (2017-2028)
Figure 37. North America Finasteride Oral Tablet Sales Share by Country (2017-2028)
Figure 38. North America Finasteride Oral Tablet Revenue Share by Country (2017-2028)
Figure 39. United States Finasteride Oral Tablet Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Finasteride Oral Tablet Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Finasteride Oral Tablet Sales Market Share by Type (2017-2028)
Figure 42. Europe Finasteride Oral Tablet Revenue Market Share by Type (2017-2028)
Figure 43. Europe Finasteride Oral Tablet Sales Market Share by Application (2017-2028)
Figure 44. Europe Finasteride Oral Tablet Revenue Market Share by Application (2017-2028)
Figure 45. Europe Finasteride Oral Tablet Sales Share by Country (2017-2028)
Figure 46. Europe Finasteride Oral Tablet Revenue Share by Country (2017-2028)
Figure 47. Germany Finasteride Oral Tablet Revenue (2017-2028) & (US$ Million)
Figure 48. France Finasteride Oral Tablet Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Finasteride Oral Tablet Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Finasteride Oral Tablet Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Finasteride Oral Tablet Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Finasteride Oral Tablet Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Finasteride Oral Tablet Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Finasteride Oral Tablet Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Finasteride Oral Tablet Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Finasteride Oral Tablet Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Finasteride Oral Tablet Revenue Share by Region (2017-2028)
Figure 58. China Finasteride Oral Tablet Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Finasteride Oral Tablet Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Finasteride Oral Tablet Revenue (2017-2028) & (US$ Million)
Figure 61. India Finasteride Oral Tablet Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Finasteride Oral Tablet Revenue (2017-2028) & (US$ Million)
Figure 63. China Taiwan Finasteride Oral Tablet Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Finasteride Oral Tablet Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Finasteride Oral Tablet Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Finasteride Oral Tablet Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Finasteride Oral Tablet Sales Market Share by Type (2017-2028)
Figure 68. Latin America Finasteride Oral Tablet Revenue Market Share by Type (2017-2028)
Figure 69. Latin America Finasteride Oral Tablet Sales Market Share by Application (2017-2028)
Figure 70. Latin America Finasteride Oral Tablet Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Finasteride Oral Tablet Sales Share by Country (2017-2028)
Figure 72. Latin America Finasteride Oral Tablet Revenue Share by Country (2017-2028)
Figure 73. Mexico Finasteride Oral Tablet Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Finasteride Oral Tablet Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Finasteride Oral Tablet Revenue (2017-2028) & (US$ Million)
Figure 76. Middle East and Africa Finasteride Oral Tablet Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Finasteride Oral Tablet Revenue Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Finasteride Oral Tablet Sales Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Finasteride Oral Tablet Revenue Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Finasteride Oral Tablet Sales Share by Country (2017-2028)
Figure 81. Middle East and Africa Finasteride Oral Tablet Revenue Share by Country (2017-2028)
Figure 82. Turkey Finasteride Oral Tablet Revenue (2017-2028) & (US$ Million)
Figure 83. Saudi Arabia Finasteride Oral Tablet Revenue (2017-2028) & (US$ Million)
Figure 84. UAE Finasteride Oral Tablet Revenue (2017-2028) & (US$ Million)
Figure 85. Finasteride Oral Tablet Value Chain
Figure 86. Finasteride Oral Tablet Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed

---